Erica B. Friedman

736 citations
27 papers · 450 indexed · h-index 10

Erica B. Friedman

25 papers receiving 436 citations

Peers

Erica B. Friedman
Comparison fields: 5 of 79
  • Oncology 221
  • Cancer Research 93
  • Immunology 89
  • Dermatology 36
  • Immunology and Allergy 20
Replace Susanna Rossari with:
Susanna Rossari Italy
Vuk Fait Czechia
Simona Pigozzi Italy
Vilma Oliveira Frick Germany
Silverio Tomao Italy
Jari Karjalainen Finland
Jordi Graells Spain
Elizabeth C. Paver Australia
Reba M. Knox United States
Zaida Morante Peru
Erica B. Friedman relative to Susanna Rossari Italy Susanna Rossari's profile →
Citations per field
00.5×1.5×2.4×
Susanna Rossari · 1×
Citations per year

Countries citing papers authored by Erica B. Friedman

Since Specialization
Citations

This map shows the geographic impact of Erica B. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica B. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica B. Friedman more than expected).

Fields of papers citing papers by Erica B. Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica B. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica B. Friedman. The network helps show where Erica B. Friedman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Erica B. Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erica B. Friedman Line = papers co-authored together Erica B. Friedman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20245
3 20232
4 20231
5 202116
6 202116
7 20203
8 20207
9 20192
10 20196
11 201814
12 201423
13 201255
14 2012103
15 20120
16 201156
17 20112
18 201027
19 200738
20
Symptomatic lower esophageal rings--treated endoscopically.
19723

About Erica B. Friedman

Erica B. Friedman is a scholar working on Oncology, Dermatology and Immunology and Allergy, having authored 27 papers that have together received 450 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (11 papers), MicroRNA in disease regulation (2 papers), Peptidase Inhibition and Analysis (2 papers), Skin Protection and Aging (2 papers), Veterinary Oncology Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cutaneous lymphoproliferative disorders research (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Oncology (221 citations), Cancer Research (93 citations) and Immunology (89 citations). Erica B. Friedman has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Iman Osman, Anna C. Pavlick, Eleazar Vega‐Saenz de Miera, W. Michelle, Russell S. Berman, Richard L. Shapiro, Yongzhao Shao, Eva Hernando, Shulian Shang and John F. Thompson. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026